Alisa B Busch

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders
    Alisa B Busch
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Am J Psychiatry 170:180-7. 2013
  2. doi request reprint Changes in guideline-recommended medication possession after implementing Kendra's law in New York
    Alisa B Busch
    McLean Hospital, 115 Mill St, Mailstop 226, Belmont, MA 02478, USA
    Psychiatr Serv 61:1000-5. 2010
  3. pmc Changes over time and disparities in schizophrenia treatment quality
    Alisa B Busch
    Department of Psychiatry, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts, USA
    Med Care 47:199-207. 2009
  4. pmc Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 64:83-7. 2013
  5. pmc Racial and ethnic disparities in postpartum depression care among low-income women
    Katy Backes Kozhimannil
    Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Psychiatr Serv 62:619-25. 2011
  6. pmc Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program and the Department of Health Care Policy, McLean Hospital and Harvard Medical School, Proctor Building, 115 Mill St, Belmont, MA 02446, USA
    Adm Policy Ment Health 33:388-97. 2006
  7. pmc Changes in the quality of care for bipolar I disorder during the 1990s
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program, McLean Hospital, Proctor Building, 115 Mill St, Belmont, MA 02478, USA
    Psychiatr Serv 58:27-33. 2007
  8. ncbi request reprint Quality of care in a Medicaid population with bipolar I disorder
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA
    Psychiatr Serv 58:848-54. 2007
  9. pmc Bipolar-I depression outpatient treatment quality and costs in usual care practice
    Alisa B Busch
    Department of Health Care Policy, Harvard Medical School, MA, USA
    Psychopharmacol Bull 41:24-39. 2008
  10. pmc Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder
    Alisa B Busch
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts 02478, USA
    Med Care 47:1217-28. 2009

Detail Information

Publications18

  1. doi request reprint The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders
    Alisa B Busch
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Am J Psychiatry 170:180-7. 2013
    ..Whether parity's effects differ by diagnosis is unknown. The authors examined this question in the context of parity implementation in the Federal Employees Health Benefits (FEHB) Program...
  2. doi request reprint Changes in guideline-recommended medication possession after implementing Kendra's law in New York
    Alisa B Busch
    McLean Hospital, 115 Mill St, Mailstop 226, Belmont, MA 02478, USA
    Psychiatr Serv 61:1000-5. 2010
    ....
  3. pmc Changes over time and disparities in schizophrenia treatment quality
    Alisa B Busch
    Department of Psychiatry, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts, USA
    Med Care 47:199-207. 2009
    ..However, there also have been considerable changes in the delivery of mental health care in the public sector, as well as increasing state concerns about Medicaid cost containment...
  4. pmc Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
    Psychiatr Serv 64:83-7. 2013
    ..S. Food and Drug Administration (FDA) communication and consensus statement warning of the drug's increased metabolic risks, but whether declines differed by racial-ethnic groups is unknown...
  5. pmc Racial and ethnic disparities in postpartum depression care among low-income women
    Katy Backes Kozhimannil
    Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Psychiatr Serv 62:619-25. 2011
    ..The goal of this study was to characterize racial-ethnic differences in mental health care utilization associated with postpartum depression in a multiethnic cohort of Medicaid recipients...
  6. pmc Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program and the Department of Health Care Policy, McLean Hospital and Harvard Medical School, Proctor Building, 115 Mill St, Belmont, MA 02446, USA
    Adm Policy Ment Health 33:388-97. 2006
    ..Most pronounced across both populations were decrements in receiving the psychosocial treatments for enrollees in the CO arrangement...
  7. pmc Changes in the quality of care for bipolar I disorder during the 1990s
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program, McLean Hospital, Proctor Building, 115 Mill St, Belmont, MA 02478, USA
    Psychiatr Serv 58:27-33. 2007
    ..This study estimated changes during the 1990s in the quality of usual-care treatment among persons diagnosed as having bipolar I disorder in a privately insured population...
  8. ncbi request reprint Quality of care in a Medicaid population with bipolar I disorder
    Alisa B Busch
    Alcohol and Drug Abuse Treatment Program, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA
    Psychiatr Serv 58:848-54. 2007
    ..This study examined whether presenting diagnosis and treatment in intensive settings (hospitalization, partial hospitalization, or residential programs) are correlated with the subsequent treatment of bipolar I disorder...
  9. pmc Bipolar-I depression outpatient treatment quality and costs in usual care practice
    Alisa B Busch
    Department of Health Care Policy, Harvard Medical School, MA, USA
    Psychopharmacol Bull 41:24-39. 2008
    ..To examine the longitudinal usual care quality and costs of bipolar-I depression treatment in adults...
  10. pmc Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder
    Alisa B Busch
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts 02478, USA
    Med Care 47:1217-28. 2009
    ..To examine racial/ethnic longitudinal disparities in antimanic medication use among adults with bipolar-I disorder...
  11. pmc Bipolar-I patient characteristics associated with differences in antimanic medication prescribing
    Alisa B Busch
    McLean Hospital, Belmont, MA, USA
    Psychopharmacol Bull 42:35-49. 2009
    ..We studied the association between patient characteristics and patient-reported antimanic medication use upon entry in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)...
  12. doi request reprint Ten-year trends in quality of care and spending for depression: 1996 through 2005
    Catherine A Fullerton
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Arch Gen Psychiatry 68:1218-26. 2011
    ....
  13. pmc Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory
    Stacie B Dusetzina
    Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 21:1251-60. 2012
    ..We examine subsequent changes in incident and prevalent SGA use among individuals with severe mental illness...
  14. pmc The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation
    Alisa B Busch
    Department of Psychiatry, Harvard Medical School, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts 02478, USA
    Med Care 44:506-12. 2006
    ..Major depressive disorder (MDD) is a prevalent but often undetected and undertreated and thus could potentially benefit from parity implementation...
  15. doi request reprint The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion
    Catherine A Fullerton
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02478, USA
    Med Care 48:372-9. 2010
    ..The case of gabapentin use in bipolar disorder provides an opportunity to study the roles of marketing, clinical evidence, and prior authorization (PA) policy on off-label medication use...
  16. doi request reprint Accurately predicting bipolar disorder mood outcomes: implications for the use of electronic databases
    Alisa B Busch
    McLean Hospital, Belmont, MA 02478, USA
    Med Care 50:311-9. 2012
    ..Monitoring mental health treatment outcomes for populations requires an understanding as to which patient information is needed in electronic format and is feasible to obtain in routine care...
  17. pmc Antidepressant reformulations: who uses them, and what are the benefits?
    Haiden A Huskamp
    Health Care Policy, Harvard Medical School in Boston, Massachusetts, USA
    Health Aff (Millwood) 28:734-45. 2009
    ..We found some evidence of benefit for subgroups of antidepressant users, although benefits varied across reformulations...
  18. ncbi request reprint The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia
    Alisa B Busch
    Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    Arch Gen Psychiatry 61:442-8. 2004
    ..The evidence on quality impacts is limited and suggests comparable quality overall, except that people with severe psychiatric disorders may be those most disadvantaged by MBHCOs...